UBS AM’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-98,191
Closed -$198K 2816
2022
Q1
$198K Hold
98,191
﹤0.01% 2684
2021
Q4
$266K Hold
98,191
﹤0.01% 2707
2021
Q3
$438K Sell
98,191
-29,175
-23% -$130K ﹤0.01% 2548
2021
Q2
$739K Buy
127,366
+50,162
+65% +$291K ﹤0.01% 2364
2021
Q1
$542K Sell
77,204
-2,915
-4% -$20.5K ﹤0.01% 2358
2020
Q4
$385K Buy
80,119
+2,107
+3% +$10.1K ﹤0.01% 2369
2020
Q3
$455K Sell
78,012
-1,743
-2% -$10.2K ﹤0.01% 2183
2020
Q2
$538K Buy
+79,755
New +$538K ﹤0.01% 2096
2019
Q4
Sell
-56,185
Closed -$221K 2910
2019
Q3
$221K Buy
56,185
+17,138
+44% +$67.4K ﹤0.01% 2551
2019
Q2
$581K Buy
39,047
+4,571
+13% +$68K ﹤0.01% 2147
2019
Q1
$856K Buy
34,476
+15,587
+83% +$387K ﹤0.01% 1884
2018
Q4
$339K Sell
18,889
-88,452
-82% -$1.59M ﹤0.01% 2154
2018
Q3
$3.15M Buy
107,341
+2,238
+2% +$65.7K ﹤0.01% 1312
2018
Q2
$4.78M Sell
105,103
-315,002
-75% -$14.3M ﹤0.01% 1163
2018
Q1
$22.2M Sell
420,105
-131,977
-24% -$6.97M 0.02% 742
2017
Q4
$37.5M Buy
552,082
+178,337
+48% +$12.1M 0.03% 543
2017
Q3
$30.8M Buy
373,745
+89,264
+31% +$7.36M 0.03% 597
2017
Q2
$26.6M Buy
284,481
+12,389
+5% +$1.16M 0.03% 635
2017
Q1
$17.3M Buy
272,092
+17,450
+7% +$1.11M 0.02% 760
2016
Q4
$11.3M Sell
254,642
-7,576
-3% -$337K 0.01% 839
2016
Q3
$9.45M Buy
262,218
+249,929
+2,034% +$9.01M 0.01% 895
2016
Q2
$169K Hold
12,289
﹤0.01% 2493
2016
Q1
$236K Sell
12,289
-1,200
-9% -$23K ﹤0.01% 2347
2015
Q4
$472K Sell
13,489
-6,828
-34% -$239K ﹤0.01% 2088
2015
Q3
$1.87M Buy
20,317
+8,717
+75% +$801K ﹤0.01% 1465
2015
Q2
$1.02M Buy
11,600
+3,000
+35% +$264K ﹤0.01% 1672
2015
Q1
$638K Buy
8,600
+400
+5% +$29.7K ﹤0.01% 1842
2014
Q4
$459K Buy
8,200
+700
+9% +$39.2K ﹤0.01% 1989
2014
Q3
$340K Hold
7,500
﹤0.01% 2075
2014
Q2
$311K Hold
7,500
﹤0.01% 2159
2014
Q1
$520K Buy
7,500
+400
+6% +$27.7K ﹤0.01% 1870
2013
Q4
$428K Buy
7,100
+2,400
+51% +$145K ﹤0.01% 1895
2013
Q3
$286K Buy
+4,700
New +$286K ﹤0.01% 2112